ReviewPharmacological reviews2025

Modern antidiabetic therapy by sodium-glucose cotransporter 2 inhibitors, glucagon-like peptide 1 receptor agonists, and dipeptidyl peptidase 4 inhibitors against cardiovascular diseases.

Sebastian Steven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.